L.J. Altfest & Co’s GSK GSK Stock Holding History

L.J. Altfest & Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,841	Closed	-$212K	–	267
2021 Q4	$212K	Buy	+3,841	New	+$200K	0.04%	234
2021 Q2	–	Sell	-15,497	Closed	-$691K	–	282
2021 Q1	$691K	Buy	15,497 +7,599	+96%	+$345K	0.16%	107
2020 Q4	$363K	Buy	+7,898	New	+$363K	0.09%	171
2015 Q1	–	Sell	-22,945	Closed	-$1.23M	–	108
2014 Q4	$1.23M	Sell	22,945 -1	-0%	-$56	1%	45
2014 Q3	$1.31M	Buy	22,946 +4	+0%	+$245	1.29%	36
2014 Q2	$1.55M	Sell	22,942 -184	-0.8%	-$12.5K	1.53%	26
2014 Q1	$1.5M	Buy	23,126 +141	+0.6%	+$9.53K	1.39%	22
2013 Q4	$1.53M	Buy	+22,985	New	+$1.49M	1.31%	23

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

L.J. Altfest & Co's GSK Position: Q1 2022 in Review

L.J. Altfest & Co sold out of GSK (GSK) in Q1 2022, closing a stake of 3,841 shares — an estimated $212K sold.

L.J. Altfest & Co first reported a position in GSK in Q4 2013 and held it in 8 quarters. The position peaked at $1.55M in Q2 2014. 929 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

L.J. Altfest & Co reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
L.J. Altfest & Co sold 3,841 GSK shares in Q1 2022, an estimated $212K.
L.J. Altfest & Co first reported a position in GSK in Q4 2013 and held it in 8 quarters.
L.J. Altfest & Co's GSK position peaked at $1.55M in Q2 2014.
929 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on L.J. Altfest & Co's 13F filing for Q1 2022, filed 2 May 2022.